BriaCell Therapeutics Corp. — Form D

BriaCell Therapeutics Corp. of WEST VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-15. The offering totals $27.2M, of which $27.2M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Jamieson BondarenkoDirectorWest Vancouver, A1
Vaughn Embro-PantalonyDirectorMississauga, A6
Martin SchmiegDirectorWest Vancouver, A1
Rebecca TaubDirectorWest Vancouver, A1
William WilliamsDirectorWest Vancouver, A1
Jamieson BondarenkoExecutive OfficerWest Vancouver, A1
Gadi LevinExecutive OfficerMa'anit, L3
William WilliamsExecutive OfficerWest Vancouver, A1
William V WilliamsDirectorAtlanta, GA
William V WilliamsExecutive OfficerAtlanta, GA
Rahoul V SharanDirectorWest Vancouver, A1
Charles WisemanDirectorWest Vancouver, A1
Charles WisemanExecutive OfficerWest Vancouver, A1
Martin V SchmiegDirectorWest Vancouver, A1
Gadi V LevinExecutive OfficerWest Vancouver, A1
Saeid BabaeiDirectorWest Vancouver, A1
Rahoul A SharanDirectorWest Vancouver, A1
Rahoul A SharanExecutive OfficerWest Vancouver, A1
Isaac A MareskyDirectorWest Vancouver, A1
Saeid BabeiDirectorWest Vancouver, A1
Chris G HealeyDirectorWest Vancouver, A1
Matthew G WrightExecutive OfficerWest Vancouver, A1
Jevin WerbesDirectorWest Vancouver, A1
Jevin WerbesExecutive OfficerWest Vancouver, A1
Rahoul SharanDirectorWest Vancouver, A1

Other filings by this issuer (3)

FiledFormOfferingSold
2018-04-10D$800K$800K
2014-12-12D$6.0M$6.0M
2014-06-20D$881K$299K

More